STRANDDX
Live / Applied — Response to non-final action entered (as of 19 Feb 2026)
What this means for you
Not registered yet, but its 16 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99287105
- Mark type
- Stylized text
- Filed
- 16 Jul 2025
- Attorney of record
- Michael R Rizzo
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic kits comprising medical diagnostic reagents to be used in exposomic testing; medical diagnostic kits comprising medical diagnostic reagents for diagnosing autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical diagnostic reagents and assays for testing hair samples
- Class 009 — Scientific and electric apparatus: Research laboratory diagnostic kits comprised of a test tube for specimen collection and a requisition form for use with an analysis device for testing hair samples for diagnosis of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer
- Class 042 — Scientific and technological services: Medical and scientific research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer diagnosis; medical research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer treatment and diagnosis; laboratory research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for scientific research purposes
- Class 044 — Medical, beauty and agricultural services: Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic purposes in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for medical purposes
Owner
- Linus Biotechnology Inc., North Brunswick, NJ, US
Prosecution history
- 19 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Dec 2025 — NON-FINAL ACTION E-MAILED
- 04 Dec 2025 — NON-FINAL ACTION WRITTEN
- 04 Dec 2025 — ASSIGNED TO EXAMINER
- 21 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 16 Jul 2025 — NEW APPLICATION ENTERED